{
    "nctId": "NCT06638294",
    "briefTitle": "Study in Patients With Breast Cancer Leptomeningeal Metastasis",
    "officialTitle": "A Translational Observational Biorepository and Management Study in Patients With Breast Cancer Leptomeningeal Metastasis: The BioLept Study",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Leptomeningeal Metastasis of Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Percentage of patients who achieve goal time to treatment recommendation",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female, aged 18 or older\n* History of breast cancer (any subtype)\n* Suspected breast cancer-related leptomeningeal metastasis (i.e., by clinical signs or symptoms (i.e., peri-oral dysesthesia, unexplained new neurological symptoms in the absence of brain metastasis), radiographic, or by cerebrospinal fluid analysis), whereby patient will be treated along an leptomeningeal disease paradigm.\n* Previous central nervous system metastasis (including leptomeningeal disease or brain metastasis) is eligible.\n* Eastern Cooperative Oncology Group (ECOG) score of \u22643 or Karnofsky performance status \u226560.\n\nExclusion Criteria:\n\n* Suspected central nervous system recurrence of hematologic malignancy, lymphoma or other solid tumor\n* Not eligible for treatment of leptomeningeal disease.",
    "sex": "ALL",
    "minimumAge": "18 Weeks",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}